These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 16115947

  • 1. Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models.
    Streck CJ, Dickson PV, Ng CY, Zhou J, Gray JT, Nathwani AC, Davidoff AM.
    Clin Cancer Res; 2005 Aug 15; 11(16):6020-9. PubMed ID: 16115947
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
    Hamner JB, Sims TL, Cutshaw A, Dickson PV, Rosati S, McGee M, Ng CY, Davidoff AM.
    J Pediatr Surg; 2008 Jan 15; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
    [Abstract] [Full Text] [Related]

  • 3. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ, Zhang Y, Zhou J, Ng C, Nathwani AC, Davidoff AM.
    J Pediatr Surg; 2005 Jan 15; 40(1):236-43. PubMed ID: 15868591
    [Abstract] [Full Text] [Related]

  • 4. Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma.
    Streck CJ, Zhou J, Ng CY, Zhang Y, Nathwani AC, Davidoff AM.
    J Am Coll Surg; 2004 Jul 15; 199(1):78-86. PubMed ID: 15217634
    [Abstract] [Full Text] [Related]

  • 5. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma.
    Dickson PV, Hamner JB, Burger RA, Garcia E, Ouma AA, Kim SU, Ng CY, Gray JT, Aboody KS, Danks MK, Davidoff AM.
    J Pediatr Surg; 2007 Jan 15; 42(1):48-53. PubMed ID: 17208540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 15; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 8. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF, Wang YG, Xiao T, Zhang KJ, Li GC, Gu JF, Chu L, Tang WH, Tan WS, Liu XY.
    Cancer Lett; 2009 Dec 28; 286(2):196-205. PubMed ID: 19564073
    [Abstract] [Full Text] [Related]

  • 9. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
    Davidoff AM, Nathwani AC, Spurbeck WW, Ng CY, Zhou J, Vanin EF.
    Cancer Res; 2002 Jun 01; 62(11):3077-83. PubMed ID: 12036917
    [Abstract] [Full Text] [Related]

  • 10. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
    Isayeva T, Ren C, Ponnazhagan S.
    Clin Cancer Res; 2005 Feb 01; 11(3):1342-7. PubMed ID: 15709207
    [Abstract] [Full Text] [Related]

  • 11. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
    Zhang X, Xu J, Lawler J, Terwilliger E, Parangi S.
    Clin Cancer Res; 2007 Jul 01; 13(13):3968-76. PubMed ID: 17606731
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
    Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS.
    Cancer Res; 2002 May 15; 62(10):2731-5. PubMed ID: 12019144
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J, Wang A, Hu Q, Lu S, Dong Z.
    Int J Oncol; 2006 Dec 15; 29(6):1405-12. PubMed ID: 17088978
    [Abstract] [Full Text] [Related]

  • 14. Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo.
    Davidoff AM, Leary MA, Ng CY, Vanin EF.
    J Pediatr Surg; 2001 Jan 15; 36(1):30-6. PubMed ID: 11150434
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun 15; 26(6):780-8. PubMed ID: 20815258
    [Abstract] [Full Text] [Related]

  • 16. Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta.
    Streck CJ, Zhang Y, Miyamoto R, Zhou J, Ng CY, Nathwani AC, Davidoff AM.
    Surgery; 2004 Aug 15; 136(2):183-9. PubMed ID: 15300178
    [Abstract] [Full Text] [Related]

  • 17. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
    Odaka M, Sterman DH, Wiewrodt R, Zhang Y, Kiefer M, Amin KM, Gao GP, Wilson JM, Barsoum J, Kaiser LR, Albelda SM.
    Cancer Res; 2001 Aug 15; 61(16):6201-12. PubMed ID: 11507073
    [Abstract] [Full Text] [Related]

  • 18. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y, Huang F, Cai H, Zhong S, Liu X, Tan WS.
    J Gene Med; 2008 May 15; 10(5):518-26. PubMed ID: 18338833
    [Abstract] [Full Text] [Related]

  • 19. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
    Cejka D, Preusser M, Fuereder T, Sieghart W, Werzowa J, Strommer S, Wacheck V.
    Anticancer Res; 2008 May 15; 28(6A):3801-8. PubMed ID: 19189667
    [Abstract] [Full Text] [Related]

  • 20. Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene.
    Tatsuta K, Tanaka S, Tajiri T, Shibata S, Komaru A, Ueda Y, Inoue M, Hasegawa M, Suita S, Sueishi K, Taguchi T, Yonemitsu Y.
    Gene Ther; 2009 Feb 15; 16(2):240-51. PubMed ID: 18987675
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.